扩散与灌注加权MRI影像组学模型或可预测弥漫性低级别胶质瘤的异柠檬酸脱氢酶突变及肿瘤侵袭性
本研究纳入127例已确定IDH突变状态和WHO分级的低级别胶质瘤患者,从常规MRI、ADC和归一化脑血容量中提取6472个影像组学特征构建多参数与常规MRI模型。多参数模型在肿瘤分级上表现优于常规模型(AUC 0.932 vs 0.555),在IDH突变预测上与常规模型相近(AUC 0.795 vs 0.729),独立验证集显示相同趋势。
要点
- 多参数MRI影像组学模型预测IDH突变与常规MRI模型性能相近(AUC 0.795 vs 0.729)。
- 多参数MRI模型在肿瘤分级上优于常规MRI模型(AUC 0.932 vs 0.555)。
- ADC特征在胶质瘤分级和IDH突变状态预测中起重要作用。
核心结论
- 多参数MRI影像组学模型在肿瘤分级上诊断性能提高,在IDH突变状态预测上诊断性能与常规MRI模型相当,ADC特征起重要作用。
研究设计与样本
- 研究纳入127例已确定IDH突变状态和WHO分级(II级或III级)的低级别胶质瘤患者,从常规MRI、表观扩散系数(ADC)和归一化脑血容量中提取6472个影像组学特征。
- 使用基于机器学习的特征选择和广义线性模型分类器构建影像组学模型,两名阅片者间分割稳定性用一致性相关系数(CCC)计算。
- 采用时间独立验证集(n=28)对模型进行测试。
诊断标准与关键数值
- 多参数MRI影像组学模型经随机森林特征选择器优化,分割稳定性CCC阈值为0.8。
- IDH突变预测:多参数MRI影像组学模型AUC 0.795,常规影像组学模型AUC 0.729。
- 肿瘤分级:含ADC特征的多参数模型AUC 0.932,常规模型AUC 0.555。
- 独立验证集:多参数MRI影像组学模型预测IDH的AUC为0.747,肿瘤分级的AUC为0.819。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether diffusion- and perfusion-weighted MRI-based radiomics features can improve prediction of isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in lower grade gliomas (LGGs) METHODS: Radiomics features (n = 6472) were extracted from multiparametric MRI including conventional MRI, apparent diffusion coefficient (ADC), and normalized cerebral blood volume, acquired on 127 LGG patients with determined IDH mutation status and grade (WHO II or III). Radiomics models were constructed using machine learning-based feature selection and generalized linear model classifiers. Segmentation stability was calculated between two readers using concordance correlation coefficients (CCCs). Diagnostic performance to predict IDH mutation and tumor grade was compared between the multiparametric and conventional MRI radiomics models using the area under the receiver operating characteristics curve (AUC). The models were tested using a temporally independent validation set (n = 28).
RESULTS: The multiparametric MRI radiomics model was optimized with a random forest feature selector, with segmentation stability of a CCC threshold of 0.8. For IDH mutation, multiparametric MR radiomics showed similar performance (AUC 0.795) to the conventional radiomics model (AUC 0.729). In tumor grading, multiparametric model with ADC features showed higher performance (AUC 0.932) than the conventional model (AUC 0.555). The independent validation set showed the same trend with AUCs of 0.747 for IDH prediction and 0.819 for tumor grading with multiparametric MRI radiomics model.
CONCLUSION: Multiparametric MRI radiomics model showed improved diagnostic performance in tumor grading and comparable diagnostic performance in IDH mutation status, with ADC features playing a significant role.
KEY POINTS: • The multiparametric MRI radiomics model was comparable with conventional MRI radiomics model in predicting IDH mutation. • The multiparametric MRI radiomics model outperformed conventional MRI in glioma grading. • Apparent diffusion coefficient played an important role in glioma grading and predicting IDH mutation status using radiomics.
引用
- Kim M, Jung SY, Park JE, et al. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma. Eur Radiol. 2019. PMID: 31828414. doi:10.1007/s00330-019-06548-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。